Growth Stocks To Watch Now – January 30th

Blackstone, Novo Nordisk A/S, BlackRock, Kazia Therapeutics, and Apollo Global Management are the five Growth stocks to watch today, according to MarketBeat’s stock screener tool. Growth stocks are shares in a company that is expected to have above-average growth in its revenue and earnings compared to others in the market. These stocks often have high price-to-earnings ratios and typically do not pay dividends, as they reinvest earnings back into the company to fuel further growth. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Blackstone (BX)

Blackstone Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies. The firm typically invests in early-stage companies. It also provide capital markets services.

Blackstone stock traded down $5.37 during midday trading on Thursday, hitting $180.01. The stock had a trading volume of 2,839,536 shares, compared to its average volume of 2,913,670. The firm’s fifty day moving average is $180.92 and its two-hundred day moving average is $161.84. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.58. The company has a market capitalization of $129.97 billion, a PE ratio of 61.86, a P/E/G ratio of 1.22 and a beta of 1.53. Blackstone has a 52-week low of $115.82 and a 52-week high of $200.96.

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

NVO stock traded up $1.70 during midday trading on Thursday, hitting $85.73. The company’s stock had a trading volume of 2,585,589 shares, compared to its average volume of 9,467,862. The firm has a market capitalization of $384.70 billion, a price-to-earnings ratio of 27.74, a price-to-earnings-growth ratio of 0.90 and a beta of 0.45. The company has a 50 day moving average of $94.32 and a two-hundred day moving average of $113.82. Novo Nordisk A/S has a 12 month low of $78.17 and a 12 month high of $148.15. The company has a quick ratio of 0.75, a current ratio of 0.94 and a debt-to-equity ratio of 0.43.

BlackRock (BLK)

BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.

Shares of BLK traded up $18.12 during midday trading on Thursday, hitting $1,070.73. 173,399 shares of the company traded hands, compared to its average volume of 770,842. The firm has a 50 day moving average of $1,024.87 and a 200-day moving average of $959.65. BlackRock has a 52 week low of $745.55 and a 52 week high of $1,082.45. The stock has a market cap of $165.83 billion, a price-to-earnings ratio of 25.49, a PEG ratio of 1.82 and a beta of 1.28. The company has a debt-to-equity ratio of 0.45, a quick ratio of 5.23 and a current ratio of 5.23.

Kazia Therapeutics (KZIA)

Kazia Therapeutics Limited operates as an oncology-focused biotechnology company. The company’s lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/AKT/mTOR pathway, which is developed as a potential therapy for glioblastoma. It also develops EVT801, a small-molecule selective inhibitor of vascular endothelial growth factor receptor 3.

Shares of NASDAQ:KZIA traded up $0.49 during trading on Thursday, reaching $1.87. The company’s stock had a trading volume of 97,227,560 shares, compared to its average volume of 5,097,136. Kazia Therapeutics has a 12 month low of $1.32 and a 12 month high of $15.80. The firm’s 50 day simple moving average is $2.97 and its two-hundred day simple moving average is $3.89.

Apollo Global Management (APO)

Apollo Global Management, Inc. is a private equity firm specializing in investments in credit, private equity, infrastructure, secondaries and real estate markets. The firm prefers to invest in private and public markets. The firm’s private equity investments include traditional buyouts, recapitalization, distressed buyouts and debt investments in real estate, corporate partner buyouts, distressed asset, corporate carve-outs, middle market, growth, venture capital, turnaround, bridge, corporate restructuring, special situation, acquisition, and industry consolidation transactions.

Apollo Global Management stock traded down $0.34 during midday trading on Thursday, reaching $170.76. The stock had a trading volume of 1,058,310 shares, compared to its average volume of 3,304,662. The company has a quick ratio of 1.44, a current ratio of 1.44 and a debt-to-equity ratio of 0.33. Apollo Global Management has a 52-week low of $95.11 and a 52-week high of $189.49. The firm has a market cap of $96.62 billion, a price-to-earnings ratio of 17.84, a price-to-earnings-growth ratio of 1.36 and a beta of 1.63. The company has a fifty day moving average of $169.91 and a 200 day moving average of $142.64.